-
1دورية أكاديمية
المؤلفون: Kaz Groen, Claudia A.M. Stege, Kazem Nasserinejad, Koen de Heer, Roel J.W. van Kampen, Rineke B.L. Leys, Noortje Thielen, Matthijs Westerman, Ka-Lung Wu, Inge Ludwig, Djamila E. Issa, Gerjo A. Velders, Marie-Christiane Vekemans, Gert-Jan Timmers, Fransien de Boer, Lidwine W. Tick, Annelies Verbrugge, Danny Buitenhuis, Sonia M. Cunha, Ellen van der Spek, Esther G.M. de Waal, Maaike Sohne, Pieter Sonneveld, Inger S. Nijhof, Saskia K. Klein, Niels W.C.J. van de Donk, Mark-David Levin, Paula F. Ypma, Sonja Zweegman
المصدر: EClinicalMedicine, Vol 63, Iss , Pp 102167- (2023)
مصطلحات موضوعية: Multiple myeloma, Elderly, Daratumumab, Ixazomib, Intermediate-fit, IMWG frailty index, Medicine (General), R5-920
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Kaz Groen, Claudia Stege, Kazem Nasserinejad, Koen de Heer, Roel J.W. van Kampen, Rineke B.L. Leys, Noortje Thielen, Matthijs Westerman, Ka-Lung Wu, Inge Ludwig, Djamila E. Issa, Gerjo A. Velders, Marie-Christiane Vekemans, Niels W.C.J. van de Donk, Gert-Jan Timmers, Fransien de Boer, Lidwine W. Tick, Ellen van der Spek, Esther G.M. de Waal, Maaike Sohne, Pieter Sonneveld, Inger S. Nijhof, Saskia K. Klein, Mark-David Levin, Paula F. Ypma, Sonja Zweegman
المصدر: HemaSphere, Vol 7, p e25266f8 (2023)
مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5
وصف الملف: electronic resource
-
3
-
4
المؤلفون: Inge Ludwig, Ellen van der Spek, Paul A F Geerts, Pieter Sonneveld, Margriet Oosterveld, Yavuz M. Bilgin, Savita Soechit, Niels W.C.J. van de Donk, Noortje Thielen, Nicole C H P de Graauw, Mark-David Levin, Gert Jan Timmers, Inger S. Nijhof, Kazem Nasserinejad, Alain Kentos, Marjolein van der Klift, Claudia A.M. Stege, Saskia K. Klein, Esther G.M. De Waal, Matthijs H Silbermann, Maaike Sohne, Marie-Christiane Vekemans, Sonja Zweegman, Roel J.W. van Kampen, Nazik Durdu-Rayman
المساهمون: UCL - (SLuc) Centre du cancer, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service d'hématologie, Internal medicine, Hematology, CCA - Cancer Treatment and quality of life
المصدر: Journal of clinical oncology, Vol. 39, no. 25, p. 2758-2767 (2021)
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(25), 2758-2767. American Society of Clinical Oncology
Stege, C A M, Nasserinejad, K, van der Spek, E, Bilgin, Y M, Kentos, A, Sohne, M, van Kampen, R J W, Ludwig, I, Thielen, N, Durdu-Rayman, N, de Graauw, N C H P, van de Donk, N W C J, de Waal, E G M, Vekemans, M C, Timmers, G J, van der Klift, M, Soechit, S, Geerts, P A F, Silbermann, M H, Oosterveld, M, Nijhof, I S, Sonneveld, P, Klein, S K, Levin, M D & Zweegman, S 2021, ' Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma : The Hovon 143 Study ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 39, no. 25, pp. 2758-2767 . https://doi.org/10.1200/JCO.20.03143مصطلحات موضوعية: Oncology, Boron Compounds, Male, Cancer Research, medicine.medical_specialty, Frail Elderly, Glycine, Dexamethasone, Ixazomib, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Medicine, Humans, Prospective Studies, Prospective cohort study, Survival rate, Multiple myeloma, Aged, Aged, 80 and over, business.industry, Daratumumab, Antibodies, Monoclonal, medicine.disease, Prognosis, Discontinuation, Clinical trial, Survival Rate, chemistry, 030220 oncology & carcinogenesis, Quality of Life, Female, business, Multiple Myeloma, 030215 immunology, medicine.drug, Follow-Up Studies
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bd16999f1d8f8fc2bbefd1520cedee3
https://hdl.handle.net/2078.1/261917 -
5
المؤلفون: Peter J. M. Valk, Yves Chalandon, Thomas Pabst, Markus G. Manz, Dimitri Breems, Maaike Sohne, Bob Löwenberg, Emanuele Ammatuna, Marjolein van der Poel, Sabine Blum, Dries Deeren, Rien van Marwijk Kooy, Dana A. Chitu, Mojca Jongen-Lavrencic, Lidwine W. Tick, Marie Cecile J.C. Legdeur, Gerwin Huls, Saskia K. Klein, Danielle van Lammeren-Venema, Gert J. Ossenkoppele, Georg Stussi, Arjan A. van de Loosdrecht, Isabelle A van Zeventer, Rinske S. Boersma, M. Fehr, Mels Hoogendoorn, Jacqueline Cloos, Laimonas Griskevicius
المساهمون: Stem Cell Aging Leukemia and Lymphoma (SALL), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Hematology laboratory, CCA - Cancer Treatment and quality of life, Hematology, University of Zurich, Huls, Gerwin, Interne Geneeskunde, MUMC+: MA Hematologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy
المصدر: Blood advances, vol. 4, no. 18, pp. 4267-4277
Blood Advances, Vol. 4, No 18 (2020) pp. 4267-4277
Blood, 4(18), 4267-4277. AMER SOC HEMATOLOGY
Blood, 4(18), 4267-4277. American Society of Hematology
Blood advances, 4(18), 4267-4277. American Society of Hematology
Huls, G, Chitu, D A, Pabst, T, Klein, S K, Stussi, G, Griskevicius, L, Valk, P J M, Cloos, J, van de Loosdrecht, A A, Breems, D, van Lammeren-Venema, D, van Zeventer, I, Boersma, R, Jongen-Lavrencic, M, Fehr, M, Hoogendoorn, M, Manz, M G, Söhne, M, Kooy, R V M, Deeren, D, van der Poel, M W M, Legdeur, M C, Tick, L, Chalandon, Y, Ammatuna, E, Blum, S, Löwenberg, B & Ossenkoppele, G J 2020, ' Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS ', Blood, vol. 4, no. 18, pp. 4267-4277 . https://doi.org/10.1182/BLOODADVANCES.2020002846
Blood advances, 4(18), 4267-4277. The American Society of Hematology
Blood Advمصطلحات موضوعية: Oncology, medicine.medical_specialty, Clinical Trials and Observations, medicine.medical_treatment, 2720 Hematology, Decitabine, MINIMAL RESIDUAL DISEASE, 610 Medicine & health, Hematopoietic stem cell transplantation, ACUTE MYELOID-LEUKEMIA, chemistry.chemical_compound, Piperidines, Internal medicine, CONVENTIONAL CARE REGIMENS, AZACITIDINE THERAPY, Humans, Medicine, Adverse effect, TREATMENT RESPONSE, Netherlands, MYELODYSPLASTIC SYNDROME, ddc:616, business.industry, Adenine, CLINICAL-RESPONSE, Myeloid leukemia, Hematology, Minimal residual disease, Transplantation, Leukemia, Myeloid, Acute, chemistry, Tolerability, HYPOMETHYLATING AGENT THERAPY, Myelodysplastic Syndromes, Ibrutinib, 10032 Clinic for Oncology and Hematology, SURVIVAL, TRIAL, business, medicine.drug
وصف الملف: application/pdf; advancesadv2020002846.pdf - application/pdf
-
6
المؤلفون: Kaz Groen, Maria B.L. Leijs, Ellen van der Spek, Esther G.M. De Waal, Pieter Sonneveld, Maarten R. Seefat, Mark-David Levin, Inger S. Nijhof, Lidwine W. Tick, Matthijs Westerman, Saskia K. Klein, Maaike Sohne, Gert-Jan Timmers, Fransien Croon-de Boer, Marie-Christiane Vekemans, Roel J.W. van Kampen, Claudia A.M. Stege, Inge Ludwig, Ka Lung Wu, Gerjo A. Velders, Sonja Zweegman, Kazem Nasserinejad, Noortje Thielen, Paula F. Ypma, Niels W.C.J. van de Donk, Koen de Heer, Djamila E. Issa
المصدر: Blood. 138:80-80
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Immunology, Low dose, Daratumumab, Cell Biology, Hematology, Newly diagnosed, medicine.disease, Biochemistry, Ixazomib, chemistry.chemical_compound, chemistry, Internal medicine, medicine, business, Multiple myeloma, Dexamethasone, INDUCTION TREATMENT, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::f7ce0479071e13b20957f5600fc2773c
https://doi.org/10.1182/blood-2021-152112 -
7دورية أكاديمية
المؤلفون: Jacobien R. Hilberink, Isabelle A. van Zeventer, Dana A. Chitu, Thomas Pabst, Saskia K. Klein, Georg Stussi, Laimonas Griskevicius, Peter J. M. Valk, Jacqueline Cloos, Arjan A. van de Loosdrecht, Dimitri Breems, Danielle van Lammeren-Venema, Rinske Boersma, Mojca Jongen-Lavrencic, Martin Fehr, Mels Hoogendoorn, Markus G. Manz, Maaike Söhne, Rien van Marwijk Kooy, Dries Deeren, Marjolein W. M. van der Poel, Marie Cecile Legdeur, Lidwine Tick, Yves Chalandon, Emanuele Ammatuna, Sabine Blum, Bob Löwenberg, Gert J. Ossenkoppele, Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON), Swiss Group for Clinical Cancer Research (SAKK), Gerwin Huls
المصدر: Blood Cancer Journal, Vol 13, Iss 1, Pp 1-9 (2023)
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2044-5385
-
8
المؤلفون: Maria B.L. Leijs, Sonja Zweegman, Nazik Durdu-Rayman, Alain Kentos, Saskia K. Klein, Nicole C. H. P. van der Burg-de Graauw, Niels W.C.J. van de Donk, Roel J. W. van Kampen, Noortje Thielen, Koen de Heer, Mark-David Levin, Esther G. M. de Waal, Kazem Nasserinejad, Pieter Sonneveld, Ellen van der Spek, Gert Jan Timmers, Claudia A.M. Stege, Inge Ludwig, Matthijs Westerman, Maaike Sohne, Marie Christiane Vekemans, Yavuz M. Bilgin
المصدر: Blood. 134:695-695
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Influenzavirus B, Mortality rate, Immunology, Cell Biology, Hematology, Biochemistry, Sudden death, Discontinuation, Transplantation, Regimen, Tolerability, Maintenance therapy, Internal medicine, Medicine, business, health care economics and organizations
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::bc4b59cccb98eeb243ce00168f2b7dc9
https://doi.org/10.1182/blood-2019-121694 -
9
المؤلفون: Sally Wetten, Evangelos Terpos, Sonja Heibl, Jo Caers, Barbara Gamberi, Xavier Leleu, Abeera Mohammad, Maaike Sohne, Florence Suzan
المصدر: Blood. 134:5578-5578
مصطلحات موضوعية: medicine.medical_specialty, education.field_of_study, business.industry, Immunology, Population, Cell Biology, Hematology, medicine.disease, Interim analysis, Biochemistry, Discontinuation, Regimen, Internal medicine, Cohort, Medicine, business, Prospective cohort study, education, Progressive disease, Lenalidomide, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::300e5cc5dc2d10c5fa5c40d5a32919c9
https://doi.org/10.1182/blood-2019-122938 -
10
المؤلفون: Pieter Sonneveld, Noortje Thielen, Maaike Sohne, Mark-David Levin, Kazem Nasserinejad, Saskia K. Klein, Paula F. Ypma, Inge Ludwig, Sonja Zweegman, Matthijs Westerman, Claudia A.M. Stege, Niels W.C.J. van de Donk, Esther G.M. De Waal, Yavuz M. Bilgin
المصدر: Blood. 132:596-596
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Influenzavirus B, Immunology, Daratumumab, Cell Biology, Hematology, Interim analysis, Biochemistry, Ixazomib, Clinical trial, Transplantation, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Tolerability, chemistry, Maintenance therapy, 030220 oncology & carcinogenesis, Internal medicine, medicine, business, 030215 immunology
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::3afc6d38e38b14d5b4bab4c359b60942
https://doi.org/10.1182/blood-2018-99-114668
Full Text via ClinicalKey 
Full Text Finder 
Find this article in full text from Springer Verlag.